{
    "SPADE_UN_15925": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_15925",
            "Peptide Name": "Alyteserin-2a [S7K, G11K]",
            "Source": "Synthetic (Derived from Alyteserin-2a)",
            "Family": "",
            "Gene": "Not found",
            "Sequence": "ILGKLLKTAAKLLSNL",
            "Sequence Length": 16,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/Notavailable"
            ],
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Anticancer"
            ],
            "Target Organism": "Tumor cells:A549 (LC50=20 μM)",
            "Hemolytic Activity": "Human erythrocytes:50% Hemolysis=38 µM",
            "Cytotoxicity": "Not available",
            "Binding Target": "Not available",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C79H146N20O20",
            "Mass": 1696.13,
            "PI": 10.3,
            "Net Charge": 3,
            "Hydrophobicity": 0.86,
            "Half Life": "Mammalian:20 hourYeast:30 minE.coli:>10 hour",
            "Literature": [
                {
                    "Title": "Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent",
                    "Pubmed ID": "22965637",
                    "Reference": "Amino Acids. 2013 Feb;44(2)715-23.",
                    "Author": "Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=22965637"
                },
                {
                    "Title": "Analogues of the frog skin peptide alyteserin-2a with enhanced antimicrobial activities against Gram-negative bacteria",
                    "Pubmed ID": "",
                    "Author": "Conlon JM, Mechkarska M, Arafat K, Attoub S, Sonnevend A"
                }
            ],
            "Frequent Amino Acids": "LKA",
            "Absent Amino Acids": "CDEFHMOPQRUVWY",
            "Basic Residues": 3,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 9,
            "Polar Residues": 8,
            "Positive Residues": 3,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_00201",
                    "Similarity": 1.0,
                    "Sequence": "KKKKVATWGNAATAAASGAVKGILG"
                },
                {
                    "SPADE_ID": "SPADE_UN_15926",
                    "Similarity": 1.0,
                    "Sequence": "ILGKLLKTAAKLLSNL"
                },
                {
                    "SPADE_ID": "SPADE_N_08367",
                    "Similarity": 1.0,
                    "Sequence": "KLLK"
                }
            ]
        }
    }
}